Lite Strategy, Inc. Severance Costs
Lite Strategy, Inc. (LITS) reported Severance Costs of $6.70 million for the 1-month period ending 2024-08-31, per its 10-K filed 2025-09-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2025-09-26
- 2024-08-31: Severance Costs 1 month $6.70M; Severance Costs 1 month as first filed $6.00M.
| Period end | Severance Costs 1 month | Severance Costs 1 month as first filed |
|---|---|---|
| 2024-08-31 | $6.70M 10-K · filed 2025-09-26 | $6.00M 10-K · filed 2024-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |